{"name":"Britecyte","slug":"britecyte","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPUHRGQVhDLWVUeTlmcmFGMFZ6YnRxTVMxcTRER203MjVZOTI4c3FYOXF1LXNTQUF5U0Y3ZHNHeDNLcVZXdjVwZG1JcFladmdFZ2YyYl9qVk1SdG9EVkQwbDBqTFFHc1BvaVlvRHNsaDN5ZGRqUC1kZEFSOExNMDBCY0wwWjNRZmliVWRNZDU3TDFKdkdCRnEzTHJ1LXc0QUJiQXBITlpoN1BINXZBUkhnQVJyaw?oc=5","date":"2025-02-20","type":"regulatory","source":"BioSpace","summary":"Britecyte’s Adipose Tissue Allograft Earns “Safe to Proceed” Status from FDA - BioSpace","headline":"Britecyte’s Adipose Tissue Allograft Earns “Safe to Proceed” Status from FDA","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}